SOLID DISPERSION COMPRISING AN ANTICANCER COMPOUND FOR IMPROVED SOLUBILITY AND EFFICACY
The present invention is related to the novel solid dispersion formulations of an anticancer compound of formula A and a process for preparing the same wherein the anticancer compound is formulated with hydrophilic polymer. The said formulation showed enhanced dissolution of the anticancer compound and improved in-vivo anticancer activity. The said formulations are useful for the treatment of various types of cancer..
Medienart: |
Patent |
---|
Erscheinungsjahr: |
2024 |
---|---|
Erschienen: |
2024 |
Enthalten in: |
Europäisches Patentamt - (2024) vom: 19. März Zur Gesamtaufnahme - year:2024 |
---|
Sprache: |
Englisch |
---|
Beteiligte Personen: |
BHARATE SONALI SANDIP [VerfasserIn] |
---|
Links: |
Volltext [kostenfrei] |
---|
Themen: |
Sonstige Themen: |
---|
Anmerkungen: |
Source: www.epo.org (no modifications made), First posted: 2024-03-19, Last update posted on www.tib.eu: 2024-04-15, Last updated: 2024-04-19 |
---|
Patentnummer: |
CA3099901 |
---|
Förderinstitution / Projekttitel: |
|
---|
PPN (Katalog-ID): |
EPA000381047 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | EPA000381047 | ||
003 | DE-627 | ||
005 | 20240419121623.0 | ||
007 | cr uuu---uuuuu | ||
008 | 240315s2024 xx |||||o 00| ||eng c | ||
035 | |a (DE-627)EPA000381047 | ||
035 | |a (EPA)CA3099901 | ||
035 | |a (EPA)69142615 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 0 | |a BHARATE SONALI SANDIP |e verfasserin |4 aut | |
245 | 1 | 0 | |a SOLID DISPERSION COMPRISING AN ANTICANCER COMPOUND FOR IMPROVED SOLUBILITY AND EFFICACY |
264 | 1 | |c 2024 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a Computermedien |b c |2 rdamedia | ||
338 | |a Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Source: www.epo.org (no modifications made), First posted: 2024-03-19, Last update posted on www.tib.eu: 2024-04-15, Last updated: 2024-04-19 | ||
520 | |a The present invention is related to the novel solid dispersion formulations of an anticancer compound of formula A and a process for preparing the same wherein the anticancer compound is formulated with hydrophilic polymer. The said formulation showed enhanced dissolution of the anticancer compound and improved in-vivo anticancer activity. The said formulations are useful for the treatment of various types of cancer. | ||
650 | 4 | |a C07D: Heterocyclic compounds (macromolecular compounds c08) | |
650 | 4 | |a A61K: Preparations for medical, dental, or toilet purposes (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms a61j0003000000;chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles a61l; soap compositions c11d) | |
650 | 4 | |a che | |
650 | 4 | |a 615 | |
700 | 0 | |a KUMAR VIKAS |e verfasserin |4 aut | |
700 | 0 | |a MINTOO MUBASHIR JAVED |e verfasserin |4 aut | |
700 | 0 | |a MONDHE DILIP MANIKRAO |e verfasserin |4 aut | |
700 | 0 | |a BHARATE SANDIP BIBISHAN |e verfasserin |4 aut | |
700 | 0 | |a VISHWAKARMA RAM |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Europäisches Patentamt |g (2024) vom: 19. März |
773 | 1 | 8 | |g year:2024 |g day:19 |g month:03 |
856 | 4 | 0 | |u https://worldwide.espacenet.com/patent/search/family/69142615/publication/CA3099901A1?q=CA3099901 |x 0 |z kostenfrei |3 Volltext |
912 | |a GBV_EPA | ||
951 | |a AR | ||
952 | |j 2024 |b 19 |c 03 |